0001467762-11-000002.txt : 20110519 0001467762-11-000002.hdr.sgml : 20110519 20110519162647 ACCESSION NUMBER: 0001467762-11-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20110519 DATE AS OF CHANGE: 20110519 EFFECTIVENESS DATE: 20110519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Naurex Inc. CENTRAL INDEX KEY: 0001467762 IRS NUMBER: 260775044 STATE OF INCORPORATION: DE FISCAL YEAR END: 1209 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-160088 FILM NUMBER: 11858224 BUSINESS ADDRESS: STREET 1: 1801 MAPLE AVENUE, SUITE 4300 CITY: EVANSTON STATE: IL ZIP: 60201 BUSINESS PHONE: 847-491-4802 MAIL ADDRESS: STREET 1: 1801 MAPLE AVENUE, SUITE 4300 CITY: EVANSTON STATE: IL ZIP: 60201 D 1 primary_doc.xml X0704 D LIVE 0001467762 Naurex Inc. 1801 MAPLE AVENUE, SUITE 4300 EVANSTON IL ILLINOIS 60201 847-491-0377 DELAWARE Nyxis Neurotherapies, Inc. None Corporation true 2006 Derek Small c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer Director Terry Gould c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Director Kenneth J. Widder c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Director Edward Chandler c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Director Joseph R. Moskal c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer Wilbur H. Gantz c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Director David C. U'Prichard c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Director Ronald M. Burch c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer James Schulz c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer Ashish Khanna c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer Amin Khan c/o Naurex Inc. 1801 Maple Avenue, Suite 4300 Evanston IL ILLINOIS 60201 Executive Officer Mitchell S. Bloom Goodwin Procter LLP 53 State Street Boston MA MASSACHUSETTS 02109 Executive Officer Biotechnology Decline to Disclose 06 false 2011-05-09 false true true true false 0 Indefinite 10959862 Indefinite The total amount sold includes the conversion of certain promissory notes. false 43 0 0 0 The Issuer will use proceeds for general working capital purposes, which includes payments to its executive officers and other employees in the ordinary course of business. false Naurex Inc. /s/Derek Small Derek Small Active Chief Executive Officer 2011-05-19